Werewolf Therapeutics, Inc.
HOWL
$0.63
-$0.03-4.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.38M | -16.37M | -17.98M | -18.09M | -20.40M |
| Total Depreciation and Amortization | 400.00K | 402.00K | 406.00K | 426.00K | 442.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 144.00K | 1.96M | 2.49M | 2.51M | 2.66M |
| Change in Net Operating Assets | -3.19M | -1.15M | -75.00K | -3.80M | 3.05M |
| Cash from Operations | -11.02M | -15.16M | -15.16M | -18.95M | -14.25M |
| Capital Expenditure | -- | -- | -- | -- | -123.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -123.00K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 2.37M | 3.27M | 388.00K | -- | 2.55M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 2.37M | 3.27M | 388.00K | -- | 2.55M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.66M | -11.88M | -14.78M | -18.95M | -11.83M |